Inhibition of nuclear export by the XPO1 inhibitor selinexor is associated with differentiation induction and prolonged survival in various murine AML models; this agent inhibits the nuclear export of not only mutated NPM1 but also several other molecules involved in leukemogenesis [198]. Here, NPM1 is linked to acute myeloid leukemia.